Azacitidine and Allogeneic Stem Cell Transplantation: When and Why?

Publisher： Karger

E-ISSN： 1421-9662|134|1|38-39

ISSN： 0001-5792

Source： Acta Haematologica, Vol.134, Iss.1, 2015-06, pp. : 38-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation

By  

Transfusion Medicine and Hemotherapy, Vol. 43, Iss. 1, 2016-0 ,pp. : 3-12

Karger

Access to resources Recommend Favorite

Second Allogeneic Stem Cell Transplantation in Myeloid Malignancies

By  

Acta Haematologica, Vol. 122, Iss. 4, 2009-10 ,pp. : 185-192

Karger

Access to resources Recommend Favorite

Role of allogeneic stem cell transplantation in mantle cell lymphoma

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 4, 2015-04 ,pp. : 290-297

John Wiley & Sons Inc

Access to resources Recommend Favorite

Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome

By  

Acta Haematologica, Vol. 134, Iss. 1, 2015-06 ,pp. : 40-48

Karger

Access to resources Recommend Favorite

‘Undo-Allo’ Stem Cell Transplantation: Another Concept to Control Allogeneic Immunotherapy?

By  

Urologia Internationalis, Vol. 72, Iss. 2, 2004-02 ,pp. : 178-

Karger

Access to resources Recommend Favorite